To study phase 1 study which compare Docecal and Taxotere in metastatic breast cancer.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2018
At a glance
- Drugs Docetaxel (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 02 Mar 2018 According to an Oasmia Pharmaceutical media release, data from the study will support the sales and marketing submission in Russia, as well as the registration discussions in other countries.
- 22 Feb 2018 According to an Oasmia Pharmaceutical media release, 228 patients had been enrolled in two studied of Docecal in comparison with Taxotere (CTP 293315 and CTP 293313 ) from 17 clinical sites in five countries.
- 22 Feb 2018 New trial record